Here, using a phosphoproteomics screen, we found that eEF2K, a kinase involved in the regulation of translation elongation, mediates sensitivity to cotreatment with PI3K and MAPK pathway inhibitors in different cancer types. Here, PIK3CA is linked to cancer.